Dow Up 0.59% Nasdaq Up 1.58%

More On ALIOF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Actelion Ltd. (ALIOF)

-Other OTC
109.81 Up 1.46(1.35%) 9:57AM EDT
Prev Close:108.35
Open:109.40
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:109.40 - 109.81
52wk Range:76.00 - 129.25
Volume:585
Avg Vol (3m):1,342
Market Cap:12.22B
P/E (ttm):17.81
EPS (ttm):6.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):19.57
P/S (ttm):6.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.68
Quarterly EPS Est (Sep-14) :1.39
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):2.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertensi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback